Skip to main content

Table 3 A summary of studies examining the outcomes of transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) in dialysis patients

From: A 91-year-old woman with severe aortic stenosis successfully underwent maintenance hemodialysis via arteriovenous fistula after transcatheter aortic valve implantation: a case report with literature review

Study/country

Design

N*

Mean age ± SD

Short-term outcome (%)

Long-term outcome (%)

Reference

Szerlip M et al. 2019/USA

Prospective

3053

76

In-hospital mortality (5.1)

1-year mortality (36.8)

 

[25]

Schymik et al. 2019/Germany

Prospective

56

76.6 ± 6.4

Perioperative mortality (10.7)

1-year survival (57.1)

3-year survival (26.8)

[23]

Al-Rashid et al. 2017/Germany

Retrospective

22

79 ± 5

30-day mortality (4.5)

2-year mortality (53)

[5]

Bhatia et al. 2017/USA

Retrospective

1708

75.3 ± 9.9

In-hospital mortality (8.2)

 

[26]

Szerlip et al. 2016/USA

Retrospective

43

76.2 ± 11

Operative mortality (14) 6-month mortality (25.6)

 

[27]

Maeda et al. 2015/Japan

Prospective

17

76.7 ± 5

1-year overall mortality (0)

 

[16]

Dumonteil et al. 2013/France, the Netherlands, Italy

Retrospective

33

76.1 ± 7.3

30-day all-cause mortality (15.2)

1-year survival (54.8)

 

[28]

Rau et al. 2012/Germany

Retrospective

10

72.3 ± 64

30-day overall mortality (0)

 

[29]

  1. *Number of dialysis patients. Only dialysis patients were depicted from each study